M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2

Youyuan Deng, Ye He, Hongjun Zhao, Lifen Ye, Jingyong Li, Zhiya Hu, Huaixiao Zhang, Chao Zhang, Qishuo Rao, Yurong Cai, Yiping Xu, Jianguo Wang

Open source

DOI
10.4149/neo_2026_260507n143
Published
2026-10-15
Container
Neoplasma
Publisher
AEPress, s.r.o.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4149/neo_2026_260507n143,
  title = {M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2},
  author = {Youyuan Deng and Ye He and Hongjun Zhao and Lifen Ye and Jingyong Li and Zhiya Hu and Huaixiao Zhang and Chao Zhang and Qishuo Rao and Yurong Cai and Yiping Xu and Jianguo Wang},
  year = {2026},
  journal = {Neoplasma},
  doi = {10.4149/neo_2026_260507n143},
  url = {https://doi.org/10.4149/neo_2026_260507n143}
}

RIS

TY  - JOUR
TI  - M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2
AU  - Youyuan Deng
AU  - Ye He
AU  - Hongjun Zhao
AU  - Lifen Ye
AU  - Jingyong Li
AU  - Zhiya Hu
AU  - Huaixiao Zhang
AU  - Chao Zhang
AU  - Qishuo Rao
AU  - Yurong Cai
AU  - Yiping Xu
AU  - Jianguo Wang
PY  - 2026
JO  - Neoplasma
DO  - 10.4149/neo_2026_260507n143
UR  - https://doi.org/10.4149/neo_2026_260507n143
ER  - 

APA

Deng, Y., He, Y., Zhao, H., Ye, L., Li, J., Hu, Z., Zhang, H., Zhang, C., Rao, Q., Cai, Y., Xu, Y., & Wang, J. (2026). M2-TAM-derived XCL2 suppresses paclitaxel sensitivity in triple-negative breast cancer by transcriptionally activating NEK2. Neoplasma. https://doi.org/10.4149/neo_2026_260507n143

Source records